Correlation Between Fate Therapeutics and Cytokinetics

Can any of the company-specific risk be diversified away by investing in both Fate Therapeutics and Cytokinetics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Fate Therapeutics and Cytokinetics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Fate Therapeutics and Cytokinetics, you can compare the effects of market volatilities on Fate Therapeutics and Cytokinetics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Fate Therapeutics with a short position of Cytokinetics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Fate Therapeutics and Cytokinetics.

Diversification Opportunities for Fate Therapeutics and Cytokinetics

0.74

Correlation Coefficient

Fate Therapeutics  Cytokinetics

Poor diversification

The 3 months correlation between Fate and Cytokinetics is 0.74. Overlapping area represents the amount of risk that can be diversified away by holding Fate Therapeutics and Cytokinetics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cytokinetics and Fate Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Fate Therapeutics are associated (or correlated) with Cytokinetics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cytokinetics has no effect on the direction of Fate Therapeutics i.e., Fate Therapeutics and Cytokinetics go up and down completely randomly.

Pair Corralation between Fate Therapeutics and Cytokinetics

Given the investment horizon of 90 days Fate Therapeutics is expected to under-perform the Cytokinetics. In addition to that, Fate Therapeutics is 1.1 times more volatile than Cytokinetics. It trades about -0.02 of its total potential returns per unit of risk. Cytokinetics is currently generating about 0.02 per unit of volatility. If you would invest  4,220  in Cytokinetics on October 13, 2024 and sell it today you would earn a total of  442.00  from holding Cytokinetics or generate 10.47% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Fate Therapeutics  vs.  Cytokinetics

Fate Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Fate Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain rather sound which may send shares a bit higher in February 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Cytokinetics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Cytokinetics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unsteady performance in the last few months, the Stock's basic indicators remain quite persistent which may send shares a bit higher in February 2025. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.

Pair Trading with Fate Therapeutics and Cytokinetics

The main advantage of trading using opposite Fate Therapeutics and Cytokinetics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Fate Therapeutics position performs unexpectedly, Cytokinetics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cytokinetics will offset losses from the drop in Cytokinetics' long position.

The idea behind Fate Therapeutics and Cytokinetics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.